Manganese porphyrin, MnTE-2-PyP 5+, acts as a pro-oxidant to potentiate glucocorticoid-induced apoptosis in lymphoma cells

Free Radical Biology and Medicine

Volumn 52, Issue 8, 2012, Pages 1272-1284

  Jaramillo, Melba C ^a   Briehl, Margaret M ^a   Crapo, James D ^b   Batinic Haberle, Ines ^c   Tome, Margaret E ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dexamethasone; Glutathione; Glutathionylation; Hydrogen peroxide; Lymphoma; MnTE 2 PyP 5+; NF B

Indexed keywords

DEXAMETHASONE; GLUTATHIONE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PORPHYRIN; PORPHYRIN MANGANESE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; LYMPHOMA CELL; NONHUMAN; OXIDATION; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; DEXAMETHASONE; DRUG SYNERGISM; GLUTATHIONE; HYDROGEN PEROXIDE; LYMPHOMA; METALLOPORPHYRINS; MICE; OXIDATION-REDUCTION; REACTIVE OXYGEN SPECIES; THYMUS NEOPLASMS;

MURINAE;

EID: 84857963236     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2012.02.001     Document Type: Article

References (42)

1. Fisher, R. I.; Gaynor, E. R.; Dahlberg, S.; Oken, M. M.; Grogan, T. M.; Mize, E. M.; Glick, J. H.; Coltman, C. A.; Miller, T. P. Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non- Hodgkin's Lymphoma. N. Engl. J. Med. 328:1002-1006; 1993.
2. Ghesquieres, H.; Ferlay, C.; Sebban, C.; Chassagne, C.; Carausu, L.; Gargi, T.; Favier, B.; Philip, I.; Blay, J. Y.; Biron, P. Combination of rituximab with chemotherapy in diffuse large B-cell lymphoma. Evaluation in daily practice before and after approval of rituximab in this indication. Hematol. Oncol. 26: 139-147; 2008.
3. Jaramillo, M. C.; Frye, J. B.; Crapo, J. D.; Briehl, M. M.; Tome, M. E. Increased Manganese Superoxide Dismutase Expression or Treatment with Manganese Porphyrin Potentiates Dexamethasone-Induced Apoptosis in Lymphoma Cells. Cancer Res. 69:5450-5457; 2009.
4. DeFreitas-Silva, G.; J. l. S., Reboutas.; Spasojevic, I.; Benov, L.; Idemori, Y. M.; Batinic-Haberle, I. SOD-like activity of Mn(II) [beta]-octabromo-mesotetrakis (N-methylpyridinium-3-yl)porphyrin equals that of the enzyme itsel. Arch. Biochem. Biophys. 477:105-112; 2008.
5. Faulkner, K. M.; Liochev, S. I.; Fridovich, I. Stable Mn(III) porphyrins mimic superoxide dismutase in vitro and substitute for it in vivo. J. Biol. Chem. 269: 23471-23476; 1994.
6. Batinic-Haberle, I.; Reboucas, J. S.; Spasojevic, I. Superoxide Dismutase Mimics: Chemistry, Pharmacology, and Therapeutic Potential. Antioxid. Redox Signal. 13: 877-918; 2010.
7. Hodge,D. R.; Xiao,W.; Peng, B.; Cherry, J. C.;Munroe, D. J.; Farrar,W. L. Enforced expression of superoxide dismutase 2/manganese superoxide dismutase disrupts autocrine interleukin-6 stimulation in human multiple myeloma cells and enhances dexamethasone-induced apoptosis. Cancer Res. 65:6255-6263; 2005.
8. Day, B. J.; Kariya, C. A Novel Class of Cytochrome P450 Reductase Redox Cyclers: Cationic Manganoporphyrins. Toxicol. Sci. 85:713-719; 2005.
9. Ferrer-Sueta, G.; Hannibal, L.; Batinic-Haberle, I.; Radi, R. Reduction of manganese porphyrins by flavoenzymes and submitochondrial particles: A catalytic cycle for the reduction of peroxynitrite. Free Radic. Biol. Med. 41:503-512; 2006.
10. Ferrer-Sueta, G.; Batinic-Haberle, I.; Spasojevic, I.; Fridovich, I.; Radi, R. Catalytic scavenging of peroxynitrite by isomeric Mn(III) N-methylpyridylporphyrins in the presence of reductants. Chem. Res. Toxicol. 12:442-449; 1999.
11. Batinic-Haberle, I.; Spasojevic, I.; Tse, H. M.; Tovmasyan, A.; Rajic, Z.; St Clair, D. K.; Vujaskovic, Z.; Dewhirst, M. W.; Piganelli, J. D. Design of Mn porphyrins for treating oxidative stress injuries and their redox-based regulation of cellular transcriptional activities. Amino, Acids; 2010.
12. Batinic-Haberle, I.; Spasojevic, I.; Fridovich, I. Tetrahydrobiopterin rapidly reduces the SOD mimic Mn(III) ortho-tetrakis(N-ethylpyridinium-2-yl) porphyrin. Free Radic. Biol. Med. 37:367-374; 2004.
13. Tome, M. E.; Baker, A. F.; Powis, G.; Payne, C. M.; Briehl, M. M. Catalase-overexpressing thymocytes are resistant to glucocorticoid-induced apoptosis and exhibit increased net tumor growth. Cancer Res. 61:2766-2773; 2001.
14. Chou, T. C.; Talalay, P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul. 22: 27-55; 1984.
15. Ahmad, I. M.; Aykin-Burns, N.; Sim, J. E.; Walsh, S. A.; Higashikubo, R.; Buettner, G. R.; Venkataraman, S.; Mackey, M. A.; Flanagan, S. W.; Oberley, L. W.; Spitz, D. R. Mitochondrial and H2O2 Mediate Glucose Deprivation-induced Stress in Human Cancer Cells. J. Biol. Chem. 280:4254-4263; 2005.
16. Hanson, G. T.; Aggeler, R.; Oglesbee, D.; Cannon, M.; Capaldi, R. A.; Tsien, R. Y.; Remington, S. J. Investigating mitochondrial redox potential with redoxsensitive green fluorescent protein indicators. J. Biol. Chem. 279:13044-13053; 2004.
17. Tome, M. E.; Jaramillo, M. C.; Briehl, M. M. Hydrogen peroxide signaling is required for glucocorticoid-induced apoptosis in lymphoma cells. Free Radic. Biol. Med. 51:2048-2059; 2011.
18. Zhou, M.; Diwu, Z.; Panchuk-Voloshina, N.; Haugland, R. P. A stable nonfluorescent derivative of resorufin for the fluorometric determination of trace hydrogen peroxide: applications in detecting the activity of phagocyte NADPH oxidase and other oxidases. Anal. Biochem. 253:162-168; 1997.
19. Royall, J. A.; Gwin, P. D.; Parks, D. A.; Freeman, B. A. Responses of vascular endothelial oxidant metabolism to lipopolysaccharide and tumor necrosis factoralpha. Arch. Biochem. Biophys. 294:686-694; 1992.
20. Tian, J.; Peehl, D. M.; Knox, S. J. Metalloporphyrin synergizes with ascorbic acid to inhibit cancer cell growth through fenton chemistry. Cancer Biother. Radiopharm. 25:439-448; 2010.
21. Franco, R.; Cidlowski, J. A. Apoptosis and glutathione: beyond an antioxidant. Cell Death Differ. 16:1303-1314; 2009.
22. Ghibelli, L.; Fanelli, C.; Rotilio, G.; Lafavia, E.; Coppola, S.; Colussi, C.; Civitareale, P.; Ciriolo, M. R. Rescue of cells from apoptosis by inhibition of active GSH extrusion. FASEB J. 12:479-486; 1998.
23. Hammond, C. L.; Madejczyk, M. S.; Ballatori, N. Activation of plasma membrane reduced glutathione transport in death receptor apoptosis of HepG2 cells. Toxicol. Appl. Pharmacol. 195:12-22; 2004.
24. Sato, T.; Machida, T.; Takahashi, S.; Iyama, S.; Sato, Y.; Kuribayashi, K.; Takada, K.; Oku, T.; Kawano, Y.; Okamoto, T.; Takimoto, R.; Matsunaga, T.; Takayama, T.; Takahashi, M.; Kato, J.; Niitsu, Y. Fas-mediated apoptosome formation is dependent on reactive oxygen species derived from mitochondrial permeability transition in Jurkat cells. J. Immunol. 173:285-296; 2004.
25. Franco, R.; Cidlowski, J. A. SLCO/OATP-like transport of glutathione in FasL-induced apoptosis: glutathione efflux is coupled to an organic anion exchange and is necessary for the progression of the execution phase of apoptosis. J. Biol. Chem. 281:29542-29557; 2006.
26. Gallogly, M. M.; Mieyal, J. J. Mechanisms of reversible protein glutathionylation in redox signaling and oxidative stress. Curr. Opin. Pharmacol. 7:381-391; 2007.
27. Velu, C. S.; Niture, S. K.; Doneanu, C. E.; Pattabiraman, N.; Srivenugopal, K. S. Human p53 is inhibited by glutathionylation of cysteines present in the proximal DNA-binding domain during oxidative stress. Biochemistry 46:7765-7780; 2007.
28. Qanungo, S.; Starke, D. W.; Pai, H. V.; Mieyal, J. J.; Nieminen, A. L. Glutathione supplementation potentiates hypoxic apoptosis by S-glutathionylation of p65-NFkappaB. J. Biol. Chem. 282:18427-18436; 2007.
29. Huang, Z.; Pinto, J. T.; Deng, H.; Richie Jr., J. P. Inhibition of caspase-3 activity and activation by protein glutathionylation. Biochem. Pharmacol. 75:2234-2244; 2008.
30. Kabe, Y.; Ando, K.; Hirao, S.; Yoshida, M.; Handa, H. Redox regulation of NF-kappaB activation: distinct redox regulation between the cytoplasm and the nucleus. Antioxid. Redox Signal. 7:395-403; 2005.
31. Unlap, T.; Jope, R. S. Inhibition of NFkB DNA binding activity by glucocorticoids in rat brain. Neurosci. Lett. 198:41-44; 1995.
32. Scheinman, R. I.; Gualberto, A.; Jewell, C. M.; Cidlowski, J. A.; Baldwin Jr., A. S. Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. Mol. Cell. Biol. 15:943-953; 1995.
33. Mitomo, K.; Nakayama, K.; Fujimoto, K.; Sun, X.; Seki, S.; Yamamoto, K. Two different cellular redox systems regulate the DNA-binding activity of the p50 subunit of NF-kappa B in vitro. Gene 145:197-203; 1994.
34. Pineda-Molina, E.; Klatt, P.; Vazquez, J.; Marina, A.; Garcia, d. L.; Perez-Sala, D.; Lamas, S. Glutathionylation of the p50 subunit of NF-kappaB: a mechanism for redox-induced inhibition of DNA binding. Biochemistry 40:14134-14142; 2001.
35. Alisi, A.; Piemonte, F.; Pastore, A.; Panera, N.; Passarelli, C.; Tozzi, G.; Petrini, S.; Pietrobattista, A.; Bottazzo, G. F.; Nobili, V. Glutathionylation of p65NF-kappaB correlates with proliferating/apoptotic hepatoma cells exposed to pro- and antioxidants. Int. J. Mol. Med. 24:319-326; 2009.
36. Lin, Y. Z.; Yao, S. Y.; Veach, R. A.; Torgerson, T. R.; Hawiger, J. Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J. Biol. Chem. 270:14255-14258; 1995.
37. Pasternack, R. F.; Banth, A.; Pasternack, J. M.; Johnson, C. S. Catalysis of the disproportionation of superoxide by metalloporphyrins. III. J. Inorg. Biochem. 15: 261-267; 1981.
38. Gardner, P. R.; Nguyen, D. D.; White, C. W. Superoxide scavenging by Mn(II/III) tetrakis (1-methyl-4-pyridyl) porphyrin in mammalian cells. Arch. Biochem. Biophys. 325:20-28; 1996.
39. Spasojevic, I.; Colvin, O. M.; Warshany, K. R.; Batinic-Haberle, I. New approach to the activation of anti-cancer pro-drugs by metalloporphyrin-based cytochrome P450 mimics in all-aqueous biologically relevant system. J. Inorg. Biochem. 100: 1897-1902; 2006.
40. Beinke, S.; Ley, S. C. Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology. Biochem. J. 382:393-409; 2004.
41. Davis, R. E.; Brown, K. D.; Siebenlist, U.; Staudt, L. M. Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J. Exp. Med. 194:1861-1874; 2001.
42. Hideshima, T.; Chauhan, D.; Richardson, P.; Mitsiades, C.; Mitsiades, N.; Hayashi, T.; Munshi, N.; Dang, L.; Castro, A.; Palombella, V.; Adams, J.; Anderson, K. C. NF-kappa B as a therapeutic target inmultiple myeloma. J. Biol. Chem. 277:16639-16647; 2002.